Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Adenocarcinoma 1

Interventions

Specimen Handling 482pembrolizumab 456Magnetic Resonance Spectroscopy 419Carboplatin 322Cyclophosphamide 317Biopsy 270Cisplatin 263Radiotherapy 238Paclitaxel 227Gemcitabine 222Bevacizumab 214Nivolumab 190fludarabine 185venetoclax 172Drug Therapy 165Blood Specimen Collection 157Dexamethasone 156Oxaliplatin 154Injections 152Capecitabine 152Fluorouracil 144Docetaxel 142Standard of Care 138Radiosurgery 136Rituximab 125Pemetrexed 115durvalumab 113atezolizumab 110Leucovorin 110Surveys and Questionnaires 104

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Prodrugs × 1 year × Clear all
NCT07332000 2026-03-20

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Candel Therapeutics, Inc.

Phase 2 Recruiting
45 enrolled
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡